The fusion oncogene RUNX1/RUNX1T1 could reprogram a large transcriptional network to establish and maintain acute myeloid leukemia (AML) via intricate PPI interactions and kinase-driven phosphorylation events in both adult and pediatric patients (21). This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.